ADVI
  • About Us
  • People
  • Insights
    • Publications
    • 2024 Presidential Election
    • Cell and Gene
    • Inflation Reduction Act
    • Case Studies
    • Events
    • News
    • Videos
  • Solutions
    • Policy, Research, and Analysis
    • Market Access
    • Reimbursement
    • Strategic Analytics, Value and Economics
      • ADVI Databoard
  • Join Us
  • Get in Touch
Get in Touch

News

In The News ADVI’s Michael Kolodziej speaks with Bloomberg Law about the unintended consequences of new “step therapy” proposal
In The News Lindsay Bealor Greenleaf Discusses Pharmacy Gag Clauses with BioWorld
In The News ADVI’s Marc Samuels, featured in Pink Sheet, gives his thoughts on MEDCAC’s upcoming review of CAR-T drug outcomes
In The News Lindsay Bealor Greenleaf talks to McKnight’s Long-Term Care News about vetoed proposal
In The News Lindsay Bealor Greenleaf Discusses Massachusetts Medicaid Drug Plan with HealthLeaders
In The News Lindsay Bealor Greenleaf Discusses Massachusetts’ 1115 Waiver Request with BioPharma Dive
In The News Lindsay Bealor Greenleaf discusses the rejection of Massachusetts’ request for a closed Medicaid formulary in Healthcare Dive
In The News Lindsay Bealor Greenleaf talks to Policy & Medicine about Azar’s plan to move drugs from Part B to D
In The News Lindsay Bealor Greenleaf talks to The Street about the Senate HELP Committee hearing on the Trump Administration’s Drug Pricing Blueprint

Posts pagination

< Previous page 1 … 20 21 22 … 25 Next page >
© 2025
ADVI
  • image description
  • image description
INNOVATE@advi.com 202.509.0760 1000 F St NW, Suite 650 Washington, DC 20004

Subscribe

to get the latest news and insights from ADVI Health